EE200200698A - Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks - Google Patents
Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviksInfo
- Publication number
- EE200200698A EE200200698A EEP200200698A EEP200200698A EE200200698A EE 200200698 A EE200200698 A EE 200200698A EE P200200698 A EEP200200698 A EE P200200698A EE P200200698 A EEP200200698 A EE P200200698A EE 200200698 A EE200200698 A EE 200200698A
- Authority
- EE
- Estonia
- Prior art keywords
- medicines
- prevention
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000185814 | 2000-06-21 | ||
| PCT/JP2001/004934 WO2001098300A1 (fr) | 2000-06-21 | 2001-06-12 | Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200200698A true EE200200698A (et) | 2004-08-16 |
| EE04941B1 EE04941B1 (et) | 2007-12-17 |
Family
ID=18686074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200698A EE04941B1 (et) | 2000-06-21 | 2001-06-12 | Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6743803B2 (et) |
| EP (1) | EP1295883A4 (et) |
| KR (1) | KR20030010740A (et) |
| CN (1) | CN100354274C (et) |
| AU (2) | AU2001262741B2 (et) |
| BR (1) | BR0111799A (et) |
| CA (1) | CA2412199A1 (et) |
| CZ (1) | CZ20024153A3 (et) |
| EE (1) | EE04941B1 (et) |
| HU (1) | HUP0301319A3 (et) |
| IL (2) | IL153439A0 (et) |
| MX (1) | MXPA02012599A (et) |
| NO (1) | NO20026148L (et) |
| NZ (1) | NZ523189A (et) |
| PL (1) | PL200537B1 (et) |
| RU (1) | RU2258506C2 (et) |
| SK (1) | SK17682002A3 (et) |
| TW (1) | TWI298068B (et) |
| WO (1) | WO2001098300A1 (et) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822097B1 (en) | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
| TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
| EP1595881A1 (en) | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| WO2010002451A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | Naphthyridin derivatives |
| JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2683818B1 (fr) | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JPH09291034A (ja) * | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
| ZA985870B (en) | 1997-07-15 | 1999-01-27 | Dainippon Pharmaceutical Co | 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives |
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| CN1361768A (zh) | 1999-06-02 | 2002-07-31 | Nps药物有限公司 | 代谢移变的谷氨酸盐受体拮抗剂和它们治疗中枢神经系统疾病的用途 |
-
2001
- 2001-06-06 TW TW090113656A patent/TWI298068B/zh not_active IP Right Cessation
- 2001-06-12 RU RU2003101405/04A patent/RU2258506C2/ru not_active IP Right Cessation
- 2001-06-12 IL IL15343901A patent/IL153439A0/xx active IP Right Grant
- 2001-06-12 SK SK1768-2002A patent/SK17682002A3/sk unknown
- 2001-06-12 US US10/311,932 patent/US6743803B2/en not_active Expired - Fee Related
- 2001-06-12 CZ CZ20024153A patent/CZ20024153A3/cs unknown
- 2001-06-12 EP EP01936958A patent/EP1295883A4/en not_active Withdrawn
- 2001-06-12 AU AU2001262741A patent/AU2001262741B2/en not_active Ceased
- 2001-06-12 CA CA002412199A patent/CA2412199A1/en not_active Abandoned
- 2001-06-12 MX MXPA02012599A patent/MXPA02012599A/es active IP Right Grant
- 2001-06-12 BR BR0111799-8A patent/BR0111799A/pt not_active Application Discontinuation
- 2001-06-12 CN CNB018142834A patent/CN100354274C/zh not_active Expired - Fee Related
- 2001-06-12 EE EEP200200698A patent/EE04941B1/et not_active IP Right Cessation
- 2001-06-12 NZ NZ523189A patent/NZ523189A/en unknown
- 2001-06-12 AU AU6274101A patent/AU6274101A/xx active Pending
- 2001-06-12 WO PCT/JP2001/004934 patent/WO2001098300A1/ja active IP Right Grant
- 2001-06-12 KR KR1020027017221A patent/KR20030010740A/ko not_active Application Discontinuation
- 2001-06-12 HU HU0301319A patent/HUP0301319A3/hu unknown
- 2001-06-12 PL PL363869A patent/PL200537B1/pl not_active IP Right Cessation
-
2002
- 2002-12-15 IL IL153439A patent/IL153439A/en not_active IP Right Cessation
- 2002-12-20 NO NO20026148A patent/NO20026148L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1295883A4 (en) | 2003-06-11 |
| HUP0301319A2 (hu) | 2003-09-29 |
| TWI298068B (en) | 2008-06-21 |
| PL200537B1 (pl) | 2009-01-30 |
| IL153439A0 (en) | 2003-07-06 |
| AU6274101A (en) | 2002-01-02 |
| CN1447809A (zh) | 2003-10-08 |
| KR20030010740A (ko) | 2003-02-05 |
| IL153439A (en) | 2007-07-24 |
| NO20026148D0 (no) | 2002-12-20 |
| RU2258506C2 (ru) | 2005-08-20 |
| CA2412199A1 (en) | 2001-12-27 |
| NZ523189A (en) | 2004-08-27 |
| BR0111799A (pt) | 2003-05-27 |
| US6743803B2 (en) | 2004-06-01 |
| NO20026148L (no) | 2003-02-20 |
| PL363869A1 (en) | 2004-11-29 |
| MXPA02012599A (es) | 2003-05-14 |
| WO2001098300A1 (fr) | 2001-12-27 |
| EE04941B1 (et) | 2007-12-17 |
| AU2001262741B2 (en) | 2005-07-07 |
| SK17682002A3 (sk) | 2003-08-05 |
| CZ20024153A3 (cs) | 2003-06-18 |
| US20030166673A1 (en) | 2003-09-04 |
| HUP0301319A3 (en) | 2008-06-30 |
| CN100354274C (zh) | 2007-12-12 |
| EP1295883A1 (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| PT1083889E (pt) | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas | |
| EE200100626A (et) | Amüloidogeense haiguse preventsioon ja ravi | |
| NO994014D0 (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
| ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
| EP1399171A4 (en) | MEDICINAL HERB COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DIABETES | |
| IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
| NO20014046D0 (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE60126321D1 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| DE60203929D1 (de) | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| NO20003229D0 (no) | Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer | |
| ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
| PT1286986E (pt) | Derivados de quinolil-piperidin-4-ilideno-metil-benzamida para o tratamento da dor | |
| AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
| NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
| NO20020784L (no) | Medikament for behandling av brudd | |
| EE200200698A (et) | Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks | |
| AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
| EE200300057A (et) | Koostis vähi profülaktikaks ja raviks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB1A | Change in the ownership or in the address of the owner | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20090612 |